Family History May Not Influences the Early Onset of Hepatocellular Carcinoma.

被引：0
|
作者：
Wei, Qiang [1 ]
Xu, Xiao [1 ]
Zhu, Yangbo [1 ]
Ling, Qi [1 ]
Ke, Qinghong [1 ]
Wang, Weiling [1 ]
Zheng, Shusen [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1,Dept Surg, Div Hepatobiliary Pancreat Surg & Liver Transplan, Hangzhou 310003, Zhejiang, Peoples R China
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-594
引用
收藏
页码：S335 / S335
页数：1
相关论文
共 50 条
  • [31] Family history and the risk of early onset persistent, early onset transient and late onset asthma
    London, S
    Gauderman, W
    Avol, E
    Rappaport, E
    Peters, J
    [J]. EPIDEMIOLOGY, 2001, 12 (04) : S95 - S95
  • [32] An epitome of the history of carcinoma.
    Park, R
    [J]. BULLETIN OF THE JOHNS HOPKINS HOSPITAL, 1903, 14 : 289 - 294
  • [33] Tyrosinemia Without Succinylacetone: Modeling a Novel Mutation in FAH in a Family With Early Onset Cirrhosis and Hepatocellular Carcinoma
    Blackburn, Patrick
    Hickey, Raymond
    Nace, Rebecca
    Giama, Nasra H.
    Chaiteerakij, Roongruedee
    Bordner, Andrew
    Kraft, Daniel
    Oglesbee, Devin
    Al-Qabandi, Wafa'a
    Grompe, Markus
    Clark, Karl J.
    Klee, Eric W.
    Gavrilov, Dimitar
    Roberts, Lewis R.
    El-Youssef, Mounif
    Ekker, Stephen C.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S111 - S111
  • [34] Association of Family History of HBV with Resectability of Hepatocellular Carcinoma
    Hu, Zhenhua
    Li, Zhiwei
    Zhou, Lin
    Wang, Weilin
    Zhang, Min
    Shen, Yan
    Zheng, Shusen
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 485 - 491
  • [35] Early diagnosis of hepatocellular carcinoma in haemochromatosis influences surgical management
    Pleass, H
    Garden, OJ
    [J]. SCOTTISH MEDICAL JOURNAL, 1998, 43 (04) : 114 - 115
  • [36] Hepatocellular carcinoma.: Epidemiology and etiological factors
    Solís-Herruzo, JA
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2003, 95 (06) : 377 - 380
  • [37] Radiofrequency ablation for unresectable hepatocellular carcinoma.
    Ng, K
    Lam, CM
    Poon, R
    Ai, V
    Yuen, J
    Tso, WK
    Fan, ST
    [J]. HEPATOLOGY, 2002, 36 (04) : 684A - 684A
  • [38] A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma
    Liu, Jinping
    Tang, Wei
    Budhu, Anuradha
    Forgues, Marshonna
    Hernandez, Maria O.
    Candia, Julian
    Kim, Yujin
    Bowman, Elise D.
    Ambs, Stefan
    Zhao, Yongmei
    Tran, Bao
    Wu, Xiaolin
    Koh, Christopher
    Surana, Pallavi
    Liang, T. Jake
    Guarnera, Maria
    Mann, Dean
    Rajaure, Manoj
    Greten, Tim F.
    Wang, Zhanwei
    Yu, Herbert
    Wang, Xin Wei
    [J]. CELL, 2020, 182 (02) : 317 - +
  • [39] Supplement use in patients with hepatocellular carcinoma.
    Lee, Valerie
    Goyal, Abhishek
    Hsu, Christine Cho-Shing
    Rodriguez, Rosa D.
    Siegel, Abby B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Sandostatin therapy for advanced hepatocellular carcinoma.
    Stadheim, LM
    Nzeako, UC
    Hassoun, Z
    LaRusso, NF
    Menon, KVN
    Roberts, LR
    Gores, GJ
    [J]. HEPATOLOGY, 2002, 36 (04) : 684A - 684A
12345